dr michael mullan presentation on roskamp institute clinic overview

Post on 18-Aug-2015

262 Views

Category:

Health & Medicine

6 Downloads

Preview:

Click to see full reader

TRANSCRIPT

Roskamp Institute ClinicRoskamp Institute Clinic

Julia Parrish, LPN, CCRC

Clinical Trials Division

Site Manager

Roskamp Institute Mission:Roskamp Institute Mission:

Conduct scientific research

Discover safe and effective new drug therapies

Successfully treat diseases of the mind

Promote healthy aging

Roskamp Institute History

Executive Leaders Dr. Michael Mullan Scientific Director Dr. Fiona Crawford Associate Director

• Not strangers to working with Alzheimer’s disease• 1991 - were among top researchers in London to identify

the gene that caused a form of early-onset AD (Swedish mutation)

Sarasota, FL

Roskamp ClinicRoskamp Clinic

Diagnose, Manage, & Treat neurological, neuropsychiatric and neurodegenerative disorders

– AD– Dementia– MCI– Depression– Head & TBI– MS– PD

Insurance / Medicare

Roskamp ClinicRoskamp Clinic

FREE Memory Screens

– Provides a cognitive base for adults as they age

Many types of memory loss are reversible

Prompt & Effective treatments benefit patients and caregivers

Call 941-256-8018 for an appointment!

Clinical Trials DivisionClinical Trials Division

Important clinical trials devoted to pharmaceutical & nutraceutical research

Roskamp Clinic StaffRoskamp Clinic Staff

Dr. Andrew Keegan– Associate Director , Roskamp Institute Clinic– Board Certified Neurologist– Moved practice to Roskamp May 2011– Principal Investigator in CTD– Special Interests

Better understanding mechanisms behind neuroinflammation in AD and MS

Dr. Deborah Burke– Sub Investigator– Board Certified Neurologist– General Neurology patients– Special Interests

Parkinson’s and other movement disorders

Dr. Michael Hoffmann– Cognitive Neurology Consultant– Director of Stroke and Cognitive Neurology

Programs at James A. Haley VA Hospital in Tampa

– Special Interests Stroke Cognitive Neurology

Clinical Trials

Alzheimer’s disease– Pfizer/Wyeth (3000,3001,3003)

Multiple Sclerosis– Sanofi-Aventis (EFC6058)– Novartis (IIRP-1280) Grant awarded to Dr. Keegan

– Biogen-idec (101JC402)– Novartis (2403)

Healthy Volunteers– Roskamp (RI-11-03)

top related